English

Tongli Pharmaceuticals (USA), Inc.

EDGAR

Quarterly report (10-Q) · filed 2014-02-14

28 filing records in this dataset, filed from 2008-01-30 to 2014-02-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.89 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 3891052 USD Source

Operating margin

19.31%

2011-09-30 · %

Exact inputs and evidence

Operating Income: 751372 USD Source
Revenue: 3891052 USD Source

Operating cash flow

-749 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1457337 USD Source
Operating Cash Flow: -708810 USD Source

Cash and cash equivalents: 111 thousand USD 2011-09-30 Source
Exact value

111362 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

18.7 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Revenue: 4402342 USD · 2010-10-01 – 2010-12-31 Source
Revenue: 14655239 USD · 2010-04-01 – 2011-03-31 Source
Revenue: 9782220 USD · 2010-04-01 – 2010-12-31 Source
Revenue: 5564834 USD · 2011-04-01 – 2011-06-30 Source
Revenue: 3891052 USD · 2011-07-01 – 2011-09-30 Source

Net income

4.91 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Net income: 1426014 USD · 2010-10-01 – 2010-12-31 Source
Net income: 4260069 USD · 2010-04-01 – 2011-03-31 Source
Net income: 2710939 USD · 2010-04-01 – 2010-12-31 Source
Net income: 1600307 USD · 2011-04-01 – 2011-06-30 Source
Net income: 337363 USD · 2011-07-01 – 2011-09-30 Source

Operating cash flow

3.74 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Operating cash flow: 2244754 USD · 2010-04-01 – 2010-12-31 Source
Operating cash flow: 583959 USD · 2010-04-01 – 2010-09-30 Source
Operating cash flow: 5781232 USD · 2010-04-01 – 2011-03-31 Source
Operating cash flow: 2244754 USD · 2010-04-01 – 2010-12-31 Source
Operating cash flow: -708810 USD · 2011-04-01 – 2011-06-30 Source
Operating cash flow: -1457337 USD · 2011-04-01 – 2011-09-30 Source
Operating cash flow: -708810 USD · 2011-04-01 – 2011-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-02-14.

Financial data available through: 2011-03-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2011-03-31
Operating income: 4 of 11 periods available· newest 2011-03-31
Net income: 6 of 11 periods available· newest 2011-03-31
Operating cash flow: 6 of 11 periods available· newest 2011-03-31
Capital expenditure: 3 of 11 periods available· newest 2010-03-31
Total assets: 6 of 11 periods available· newest 2011-03-31
Total liabilities: 2 of 11 periods available· newest 2011-03-31
Current assets: 6 of 11 periods available· newest 2011-03-31
Current liabilities: 6 of 11 periods available· newest 2011-03-31
Cash and cash equivalents: 6 of 11 periods available· newest 2011-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+70.6%

Prior period

USD 8.59 million

2009-04-01 – 2010-03-31
Current period

USD 14.66 million

2010-04-01 – 2011-03-31

Exact inputs and evidence

14655239 − 8591951 = 6063288 USD

8591951 USD · 2009-04-01 – 2010-03-31
Inspect prior input Prior source
14655239 USD · 2010-04-01 – 2011-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Tongli Pharmaceuticals (USA), Inc. · 2011-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Year-over-year change in Revenue: 6063288 USD Concept: fundies:Revenue Period: 2010-04-01 to 2011-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 14655239 USD (2010-04-01 to 2011-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#7925 Input fundies:Revenue: 8591951 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#7925
The citation records this snapshot. The page link may show a newer release later.
Net income
+337.9%

Prior period

USD 972,812

2009-04-01 – 2010-03-31
Current period

USD 4.26 million

2010-04-01 – 2011-03-31

Exact inputs and evidence

4260069 − 972812 = 3287257 USD

972812 USD · 2009-04-01 – 2010-03-31
Inspect prior input Prior source
4260069 USD · 2010-04-01 – 2011-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Tongli Pharmaceuticals (USA), Inc. · 2011-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Year-over-year change in Net income: 3287257 USD Concept: fundies:NetIncome Period: 2010-04-01 to 2011-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 4260069 USD (2010-04-01 to 2011-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8364 Input fundies:NetIncome: 972812 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8364
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+173.4%

Prior period

USD 2.11 million

2009-04-01 – 2010-03-31
Current period

USD 5.78 million

2010-04-01 – 2011-03-31

Exact inputs and evidence

5781232 − 2114395 = 3666837 USD

2114395 USD · 2009-04-01 – 2010-03-31
Inspect prior input Prior source
5781232 USD · 2010-04-01 – 2011-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Tongli Pharmaceuticals (USA), Inc. · 2011-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Year-over-year change in Operating cash flow: 3666837 USD Concept: fundies:OperatingCashFlow Period: 2010-04-01 to 2011-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 5781232 USD (2010-04-01 to 2011-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8556 Input fundies:OperatingCashFlow: 2114395 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8556
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2010-04-01 – 2011-03-31

Revenue USD 14.66 million 100% of revenue
Cost of revenue USD 7.73 million 53% of revenue
Operating expenses USD 1.04 million 7.1% of revenue
Operating income USD 5.88 million 40% of revenue
Tax, interest and other Derived USD 1.62 million 11% of revenue
Net income USD 4.26 million 29% of revenue

Cash

Operating cash flow USD 5.78 million 39% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 13%78%
2009 26%72%
2010 11%11%78%
2011 29%11%60%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	0	Unavailable	Unavailable	Unavailable	-1200	Unavailable	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -1200 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 0 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	0	Unavailable	Unavailable	Unavailable	-41225	Unavailable	Source 2007-01-01 – 2007-12-31: 0 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -41225 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -7612 USD Inspect Operating Cash Flow Open source
2008 2007-04-01 – 2008-03-31	1974279	1547456 Derived	426823	161386 Derived	265437	-117286 Derived	Source 2007-04-01 – 2008-03-31: 1974279 USD Inspect Revenue Open source 2007-04-01 – 2008-03-31: 426823 USD Inspect Operating Income Open source 2007-04-01 – 2008-03-31: 265437 USD Inspect Net Income Open source 2007-04-01 – 2008-03-31: 458482 USD Inspect Operating Cash Flow Open source 2007-04-01 – 2008-03-31: 575768 USD Inspect Capital Expenditure Open source
2009 2008-04-01 – 2009-03-31	7442445	5342272 Derived	2100173	195334 Derived	1904839	1306047 Derived	Source 2008-04-01 – 2009-03-31: 7442445 USD Inspect Revenue Open source 2008-04-01 – 2009-03-31: 2100173 USD Inspect Operating Income Open source 2008-04-01 – 2009-03-31: 1904839 USD Inspect Net Income Open source 2008-04-01 – 2009-03-31: 1306918 USD Inspect Operating Cash Flow Open source 2008-04-01 – 2009-03-31: 871 USD Inspect Capital Expenditure Open source
2010 2009-04-01 – 2010-03-31	8591951	6690310 Derived	1901641	928829 Derived	972812	2114395 Derived	Source 2009-04-01 – 2010-03-31: 8591951 USD Inspect Revenue Open source 2009-04-01 – 2010-03-31: 1901641 USD Inspect Operating Income Open source 2009-04-01 – 2010-03-31: 972812 USD Inspect Net Income Open source 2009-04-01 – 2010-03-31: 2114395 USD Inspect Operating Cash Flow Open source 2009-04-01 – 2010-03-31: 0 USD Inspect Capital Expenditure Open source
2011 2010-04-01 – 2011-03-31	14655239	8775010 Derived	5880229	1620160 Derived	4260069	Unavailable	Source 2010-04-01 – 2011-03-31: 14655239 USD Inspect Revenue Open source 2010-04-01 – 2011-03-31: 5880229 USD Inspect Operating Income Open source 2010-04-01 – 2011-03-31: 4260069 USD Inspect Net Income Open source 2010-04-01 – 2011-03-31: 5781232 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 14.7M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Revenue	0	Revenue: 0 Open source
20072007-12-31	Revenue	0	Revenue: 0 Open source
20082008-03-31	Revenue	1974279	Revenue: 1974279 Open source
20092009-03-31	Revenue	7442445	Revenue: 7442445 Open source
20102010-03-31	Revenue	8591951	Revenue: 8591951 Open source
20112011-03-31	Revenue	14655239	Revenue: 14655239 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

70.6% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20082008-03-31	Year over year	No prior comparable period	Revenue: 1974279 Open source
20092009-03-31	Year over year	277%	Revenue: 7442445 Open source Revenue: 1974279 Open source
20102010-03-31	Year over year	15.4%	Revenue: 8591951 Open source Revenue: 7442445 Open source
20112011-03-31	Year over year	70.6%	Revenue: 14655239 Open source Revenue: 8591951 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 40.1% 2011

Net margin 29.1% 2011

Free cash flow margin 24.6% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2006-12-31	Operating margin	Not reported	Revenue: 0 Open source
2007-12-31	Operating margin	Not reported	Revenue: 0 Open source
20082008-03-31	Operating margin	21.6%	Operating Income: 426823 Open source Revenue: 1974279 Open source
20092009-03-31	Operating margin	28.2%	Operating Income: 2100173 Open source Revenue: 7442445 Open source
20102010-03-31	Operating margin	22.1%	Operating Income: 1901641 Open source Revenue: 8591951 Open source
20112011-03-31	Operating margin	40.1%	Operating Income: 5880229 Open source Revenue: 14655239 Open source
20062006-12-31	Net margin	Not reported	Net Income: -1200 Open source Revenue: 0 Open source
20072007-12-31	Net margin	Not reported	Net Income: -41225 Open source Revenue: 0 Open source
20082008-03-31	Net margin	13.4%	Net Income: 265437 Open source Revenue: 1974279 Open source
20092009-03-31	Net margin	25.6%	Net Income: 1904839 Open source Revenue: 7442445 Open source
20102010-03-31	Net margin	11.3%	Net Income: 972812 Open source Revenue: 8591951 Open source
20112011-03-31	Net margin	29.1%	Net Income: 4260069 Open source Revenue: 14655239 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -7612 Open source
20082008-03-31	Free cash flow margin	-5.9%	Revenue: 1974279 Open source Operating Cash Flow: 458482 Open source Capital Expenditure: 575768 Open source
20092009-03-31	Free cash flow margin	17.5%	Revenue: 7442445 Open source Operating Cash Flow: 1306918 Open source Capital Expenditure: 871 Open source
20102010-03-31	Free cash flow margin	24.6%	Revenue: 8591951 Open source Operating Cash Flow: 2114395 Open source Capital Expenditure: 0 Open source
20112011-03-31	Free cash flow margin	Not reported	Revenue: 14655239 Open source Operating Cash Flow: 5781232 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 5.8M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Operating cash flow	0	Operating Cash Flow: 0 Open source
20072007-12-31	Operating cash flow	-7612	Operating Cash Flow: -7612 Open source
20082008-03-31	Operating cash flow	458482	Operating Cash Flow: 458482 Open source
20092009-03-31	Operating cash flow	1306918	Operating Cash Flow: 1306918 Open source
20102010-03-31	Operating cash flow	2114395	Operating Cash Flow: 2114395 Open source
20112011-03-31	Operating cash flow	5781232	Operating Cash Flow: 5781232 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 2.1M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
20072007-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7612 Open source
20082008-03-31	Free cash flow	-117286	Operating Cash Flow: 458482 Open source Capital Expenditure: 575768 Open source
20092009-03-31	Free cash flow	1306047	Operating Cash Flow: 1306918 Open source Capital Expenditure: 871 Open source
20102010-03-31	Free cash flow	2114395	Operating Cash Flow: 2114395 Open source Capital Expenditure: 0 Open source
20112011-03-31	Free cash flow	Unavailable	Operating Cash Flow: 5781232 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

16% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2006-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 32388 Open source
2008-03-31	Liabilities / assets	Not reported	Total Assets: 9042348 Open source
2009-03-31	Liabilities / assets	Not reported	Total Assets: 9556196 Open source
20102010-03-31	Liabilities / assets	12.6%	Total Liabilities: 1445746 Open source Total Assets: 11510095 Open source
20112011-03-31	Liabilities / assets	16%	Total Liabilities: 2862834 Open source Total Assets: 17866772 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.22× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 7200 Open source
20072007-12-31	Current assets / current liabilities	1.12×	Current Assets: 32388 Open source Current Liabilities: 28813 Open source
20082008-03-31	Current assets / current liabilities	0.43×	Current Assets: 1228569 Open source Current Liabilities: 2865063 Open source
20092009-03-31	Current assets / current liabilities	0.84×	Current Assets: 1450714 Open source Current Liabilities: 1726164 Open source
20102010-03-31	Current assets / current liabilities	1.72×	Current Assets: 1961057 Open source Current Liabilities: 1137041 Open source
20112011-03-31	Current assets / current liabilities	2.22×	Current Assets: 3978646 Open source Current Liabilities: 1790763 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 1,200 Exact value Exact value: -1200 USD 2006-01-01 – 2006-12-31: -1200 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tongli Pharmaceuticals (USA), Inc. · 2006-12-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Net Income: -1200 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1200 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001019687-08-000385.txt#1330 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2006-01-01 – 2006-12-31: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tongli Pharmaceuticals (USA), Inc. · 2006-12-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001019687-08-000385.txt#1339 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 41,225 Exact value Exact value: -41225 USD 2007-01-01 – 2007-12-31: -41225 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tongli Pharmaceuticals (USA), Inc. · 2007-12-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Net Income: -41225 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -41225 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001019687-08-000385.txt#1330 The citation records this snapshot. The page link may show a newer release later.	−USD 7,612 Exact value Exact value: -7612 USD 2007-01-01 – 2007-12-31: -7612 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tongli Pharmaceuticals (USA), Inc. · 2007-12-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Operating Cash Flow: -7612 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7612 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001019687-08-000385.txt#1339 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2007-04-01 – 2008-03-31	USD 265,437 Exact value Exact value: 265437 USD 2007-04-01 – 2008-03-31: 265437 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tongli Pharmaceuticals (USA), Inc. · 2008-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Net Income: 265437 USD Concept: fundies:NetIncome Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ANetIncome&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:NetIncome: 265437 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-09-037510.txt#9277 The citation records this snapshot. The page link may show a newer release later.	USD 458,482 Exact value Exact value: 458482 USD 2007-04-01 – 2008-03-31: 458482 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tongli Pharmaceuticals (USA), Inc. · 2008-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Operating Cash Flow: 458482 USD Concept: fundies:OperatingCashFlow Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3AOperatingCashFlow&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 458482 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-09-037510.txt#9472 The citation records this snapshot. The page link may show a newer release later.	USD 575,768 Exact value Exact value: 575768 USD 2007-04-01 – 2008-03-31: 575768 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Tongli Pharmaceuticals (USA), Inc. · 2008-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Capital Expenditure: 575768 USD Concept: fundies:CapitalExpenditure Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ACapitalExpenditure&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 575768 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-09-037510.txt#9512 The citation records this snapshot. The page link may show a newer release later.	−USD 117,286 Calculation and evidence 458482 − 575768 USD Exact free cash flow: -117286 USD 2007-04-01 – 2008-03-31: 458482 USD · Inspect Operating Cash Flow · Source 2007-04-01 – 2008-03-31: 575768 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Tongli Pharmaceuticals (USA), Inc. · 2008-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Free cash flow: -117286 USD Concept: free-cash-flow Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 458482 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-09-037510.txt#9472 Input fundies:CapitalExpenditure: 575768 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-09-037510.txt#9512 The citation records this snapshot. The page link may show a newer release later.
2009 2008-04-01 – 2009-03-31	USD 1.9 million Exact value Exact value: 1904839 USD 2008-04-01 – 2009-03-31: 1904839 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tongli Pharmaceuticals (USA), Inc. · 2009-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Net Income: 1904839 USD Concept: fundies:NetIncome Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ANetIncome&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:NetIncome: 1904839 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-10-035731.txt#9862 The citation records this snapshot. The page link may show a newer release later.	USD 1.31 million Exact value Exact value: 1306918 USD 2008-04-01 – 2009-03-31: 1306918 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tongli Pharmaceuticals (USA), Inc. · 2009-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Operating Cash Flow: 1306918 USD Concept: fundies:OperatingCashFlow Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3AOperatingCashFlow&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1306918 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-10-035731.txt#10085 The citation records this snapshot. The page link may show a newer release later.	USD 871 Exact value Exact value: 871 USD 2008-04-01 – 2009-03-31: 871 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Tongli Pharmaceuticals (USA), Inc. · 2009-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Capital Expenditure: 871 USD Concept: fundies:CapitalExpenditure Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ACapitalExpenditure&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 871 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-10-035731.txt#10125 The citation records this snapshot. The page link may show a newer release later.	USD 1.31 million Calculation and evidence 1306918 − 871 USD Exact free cash flow: 1306047 USD 2008-04-01 – 2009-03-31: 1306918 USD · Inspect Operating Cash Flow · Source 2008-04-01 – 2009-03-31: 871 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Tongli Pharmaceuticals (USA), Inc. · 2009-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Free cash flow: 1306047 USD Concept: free-cash-flow Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1306918 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-10-035731.txt#10085 Input fundies:CapitalExpenditure: 871 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-10-035731.txt#10125 The citation records this snapshot. The page link may show a newer release later.
2010 2009-04-01 – 2010-03-31	USD 972,812 Exact value Exact value: 972812 USD 2009-04-01 – 2010-03-31: 972812 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tongli Pharmaceuticals (USA), Inc. · 2010-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Net Income: 972812 USD Concept: fundies:NetIncome Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ANetIncome&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:NetIncome: 972812 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8364 The citation records this snapshot. The page link may show a newer release later.	USD 2.11 million Exact value Exact value: 2114395 USD 2009-04-01 – 2010-03-31: 2114395 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tongli Pharmaceuticals (USA), Inc. · 2010-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Operating Cash Flow: 2114395 USD Concept: fundies:OperatingCashFlow Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3AOperatingCashFlow&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2114395 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8556 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-04-01 – 2010-03-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Tongli Pharmaceuticals (USA), Inc. · 2010-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ACapitalExpenditure&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-10-035731.txt#10125 The citation records this snapshot. The page link may show a newer release later.	USD 2.11 million Calculation and evidence 2114395 − 0 USD Exact free cash flow: 2114395 USD 2009-04-01 – 2010-03-31: 2114395 USD · Inspect Operating Cash Flow · Source 2009-04-01 – 2010-03-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Tongli Pharmaceuticals (USA), Inc. · 2010-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Free cash flow: 2114395 USD Concept: free-cash-flow Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2114395 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8556 Input fundies:CapitalExpenditure: 0 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-10-035731.txt#10125 The citation records this snapshot. The page link may show a newer release later.
2011 2010-04-01 – 2011-03-31	USD 4.26 million Exact value Exact value: 4260069 USD 2010-04-01 – 2011-03-31: 4260069 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tongli Pharmaceuticals (USA), Inc. · 2011-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Net Income: 4260069 USD Concept: fundies:NetIncome Period: 2010-04-01 to 2011-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3ANetIncome&period=2011-03-31&surface=latest&period_type=duration&start=2010-04-01&unit=USD&dimensions= Input fundies:NetIncome: 4260069 USD (2010-04-01 to 2011-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8364 The citation records this snapshot. The page link may show a newer release later.	USD 5.78 million Exact value Exact value: 5781232 USD 2010-04-01 – 2011-03-31: 5781232 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tongli Pharmaceuticals (USA), Inc. · 2011-03-31 Tongli Pharmaceuticals (USA), Inc. (edgar:1052284) Operating Cash Flow: 5781232 USD Concept: fundies:OperatingCashFlow Period: 2010-04-01 to 2011-03-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1052284/explain?concept=fundies%3AOperatingCashFlow&period=2011-03-31&surface=latest&period_type=duration&start=2010-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5781232 USD (2010-04-01 to 2011-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1052284/0001144204-11-040622.txt#8556 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001052284, 1052284, edgar:1052284

Also known as AIM SMART CORP, American Tony Pharmaceuticals, Inc.

Tongli Pharmaceuticals (USA), Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2011 2010-04-01 – 2011-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation